This is a paid press release. Contact the press release distributor directly with any inquiries.
POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities
PR Newswire
Wed, July 15, 2026 at 5:30 PM GMT+5:30
5 min read
- POM
-17.52%
GUANGZHOU, China, July 15, 2026 /PRNewswire/ — POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today highlighted its ongoing efforts to strengthen its healthcare data ecosystem, by leveraging real-world data (“RWD”), artificial intelligence (“AI”), wearable technologies, remote patient monitoring (“RPM”) capabilities and physician resources to enable more personalized, predictive and continuous healthcare management.
As digital transformation accelerates across healthcare systems worldwide, RWD is emerging as a critical foundation for AI-enabled healthcare innovation. Unlike traditional clinical datasets, RWD—generated through daily healthcare interactions, connected devices, patient monitoring and healthcare services—provides broader and richer insights into patient behaviors, disease progression and long-term health management needs. Market projections underscore the growing significance of RWD
According to Precedence Research, the global RWD market is projected to grow from approximately US$2.15 billion in 2026 to approximately US$7.11 billion by 2035, representing a compound annual growth rate (“CAGR”) of 14.23% from 2026 to 2035. The report attributes this growth in part to the increasing adoption of RWD in clinical research and personalized healthcare solutions, alongside the expansion of telehealth services, increased reliance on remote patient data collection, and advancements in wearable and Internet of Things-enabled health devices.
Similarly, Coherent Market Insights estimates that the global RWD market will grow from approximately US$2.73 billion in 2026 to approximately US$7.08 billion by 2033, at a CAGR of 14.6% during the forecast period. Key drivers cited include the increasing adoption of electronic health records, growing demand for evidence-based medicine, regulatory support and continued advances in AI and data analytics. It also notes that demand for personalized medicine and chronic disease management is accelerating the adoption of RWD across healthcare systems.
Building a Healthcare Data Ecosystem to Power AI Capabilities
In response to these industry trends, Pomdoctor continues to develop a comprehensive healthcare data ecosystem designed to support AI-driven chronic disease management and predictive healthcare services
The Company’s data-driven healthcare framework aggregates diverse RWDms, physician interactions, patient health management activities and healthcare payment-related insights. This multidimensional data ecosystem aims to create a continuous feedback loop that strengthens AI analytics capabilities and supports the development of deeper personalized healthcare solutions
